The Funds investment objective is to achieve long term capital growth from a portfolio primarily made up of the shares of continental European companies.
Name | % Net Assets |
---|---|
Linde AG | 3.9% |
Saipem | 3.7% |
Siemens AG | 3.7% |
Sanofi | 3.6% |
LVMH Moet Hennessy Louis Vuitton SA | 3.4% |
Sap AG ADR | 3.0% |
Allianz SE | 2.9% |
UBS AG | 2.8% |
Schneider Electric | 2.7% |
Novo Nordisk A/S | 2.7% |
Key | % Net Assets |
---|---|
Linde AG | 3.9% |
Saipem | 3.7% |
Siemens AG | 3.7% |
Sanofi | 3.6% |
Other | 85.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 585.20p |
Currency | GBP |
Change | -1.10p |
% | -0.19% |
YTD change | -17.30p |
YTD % | -2.87% |
Fund Inception | 12/09/1988 |
---|---|
Fund Manager | Colin Stone |
TER | 1.72 (28-Feb-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £250 |
Savings | £50 |
Charges | |
---|---|
Initial | 3.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.10 |
You are here: research